We serve L-Leucyl-D-valine CAS:17665-00-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name: L-Leucyl-D-valine
CAS.NO: 17665-00-8
Molecular Formula:C11H22N2O3
Molecular Weight:230.304
Synonyms:
2-(2-Amino-N-methylacetamido)acetic acid
N-glycyl-sarcosine
Glycylsarcosine
Glycyl-sarcosine
H-Gly-Sar-OH
Gly-Sarcosin
Gly-Sar
Physical and Chemical Properties:
Density: 1.1±0.1 g/cm3
Boiling point: 421.9±30.0 °C at 760 mmHg
Melting point: /
Flash point: 209.0±24.6 °C
Refractive index: 1.482
Specification:
Appearance: White Crystalline Powder
Purity:≥98%
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store at -20ºC.Keep the container tightly closed, put it in a tight dispenser, and store in a cool, dry place.
Application:pharmaceutical intermediates.
Contact us for information like L-Leucyl-D-valine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Gly-Sar physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Gly-Sarcosin Use and application,Gly-Sarcosin technical grade,usp/ep/jp grade.
Related News: With the structural upgrade of the pharmaceutical industry in developed countries, the transfer of related industrial chains has taken place globally, and it has also had a profound impact on Chinese pharmaceutical companies. near4-[(2-ethoxybenzoyl)amino]-2-methyl-5-propylpyrazole-3-carboxamide manufacturer Professionally produce and submit DMF files, and supplement data at any time during the patent challenge of formulation companies.3,5-Difluorotoluene supplier The fine and functional chemicals sector provides new growth drivers.N-Ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline vendor Retrogenix’s proprietary cell microarray technology provides a fast, accurate and effective solution for determining the primary target and secondary target (off-target) activities of antibodies, proteins, cell therapies, small molecules and viruses.GlaxoSmithKline (GSK) is at the bottom of the top 20 list with the lowest percentage R&D spend/annual revenue at 12%.”
